Published on 3 Aug 2023 on Zacks via Yahoo Finance
DermTech, Inc. (DMTK) Reports Q2 Loss, Tops Revenue Estimates
DermTech, Inc. (DMTK) came out with a quarterly loss of $0.99 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.99 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -4.21%. A quarter ago, it was expected that this company would post a loss of $0.90 per share when it actually produced a loss of $1.02, delivering a surprise of -13.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.